Data gathered: May 29
AI Stock Analysis - McKesson (MCK)
Analysis generated September 27, 2024. Powered by Chat GPT.
McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology, specialty care, and healthcare information technology. The company distributes pharmaceuticals at a national network of distribution centers and provides healthcare management tools and scalable solutions to reduce costs, improve operational efficiency and enhance the quality of care. With a robust history of innovation and leadership, McKesson plays a pivotal role in the healthcare industry.
Stock Alerts - McKesson (MCK)
![]() |
McKesson | May 29 Insider Alert: Rutledge Napoleon B JR is continuing selling shares |
![]() |
McKesson | May 24 Insider Alert: Smith LeAnn B is selling shares |
![]() |
McKesson | May 22 Insider Alert: Rutledge Napoleon B JR is selling shares |
![]() |
McKesson | May 13 Employee Rating is up by 2.7% over the last month. |
Download our app to get future alerts delivered in real-time.
Alternative Data for McKesson
Alternative Data | Value | 3m Change | Trend | Benchmark | |
---|---|---|---|---|---|
Job Posts | 419 | Sign up | Sign up | Sign up | |
Sentiment | 96 | Sign up | Sign up | Sign up | |
Webpage traffic | 2,600,000 | Sign up | Sign up | Sign up | |
Employee Rating | 76 | Sign up | Sign up | Sign up | |
Google Trends | 70 | Sign up | Sign up | Sign up | |
Patents | 76 | Sign up | Sign up | Sign up | |
4chan Mentions | N/A | Sign up | Sign up | Sign up | |
Facebook Engagement | 191 | Sign up | Sign up | Sign up | |
Facebook Followers | 27,467 | Sign up | Sign up | Sign up | |
Instagram Followers | 10,578 | Sign up | Sign up | Sign up | |
Reddit Mentions | N/A | Sign up | Sign up | Sign up | |
Stocktwits Mentions | 5 | Sign up | Sign up | Sign up | |
Stocktwits Subscribers | 3,761 | Sign up | Sign up | Sign up | |
Twitter Followers | 21,756 | Sign up | Sign up | Sign up | |
Twitter Mentions | 10 | Sign up | Sign up | Sign up | |
News Mentions | N/A | Sign up | Sign up | Sign up | |
Customer reviews | N/A | Sign up | Sign up | Sign up | |
Lobbying Cost | $420,000 | Sign up | Sign up | Sign up | |
Business Outlook | 68 | Sign up | Sign up | Sign up | |
Linkedin Employees | 22,826 | Sign up | Sign up | Sign up |
About McKesson
Incorporated in 1833, Texas-based McKesson Corp. provides pharmaceuticals, health information technology, medical supplies, and care management tools. The company operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions, International, and Medical-Surgical Solutions.

Price | $712.13 |
Target Price | Sign up |
Volume | 638,530 |
Market Cap | $90B |
Year Range | $477.99 - $726.4 |
Dividend Yield | 0.4% |
PE Ratio | 27.86 |
Analyst Rating | 83% buy |
Industry | Digital health |
In the news
![]() |
Here's Why McKesson (MCK) is a Strong Momentum StockMay 27 - Yahoo |
![]() |
Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending StockMay 27 - Yahoo |
![]() |
Here's How Much You Would Have Made Owning McKesson Stock In The Last 15 YearsMay 27 - Biztoc.com |
![]() |
MCK vs. CAH: Which Drug Distribution Giant Has the Healthier Outlook?May 26 - Yahoo |
![]() |
An Intrinsic Calculation For McKesson Corporation (NYSE:MCK) Suggests It's 33% UndervaluedMay 22 - Yahoo |
![]() |
McKesson Stock: Is Wall Street Bullish or Bearish?May 22 - Biztoc.com |
Financial performance View All
Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
---|---|---|---|---|---|---|
Q1 '25 | 90.8B | 87.2B | 3.64B | 1.26B | 0 | 10.120 |
Q4 '24 | 95.3B | 92B | 3.28B | 879M | 1.45B | 8.030 |
Q3 '24 | 93.7B | 90.4B | 3.25B | 241M | 775M | 7.070 |
Q2 '24 | 79.3B | 76.3B | 2.96B | 915M | 1.32B | 7.880 |
Q1 '24 | 76.4B | 72.9B | 3.46B | 791M | 1.41B | 6.180 |
Insider Transactions View All
Rutledge Napoleon B JR filed to sell 1,081 shares at $714.3. May 28 '25 |
Rutledge Napoleon B JR filed to sell 2,067 shares at $715.2. May 28 '25 |
Vitalone Britt J. filed to sell 14,922 shares at $715.2. May 28 '25 |
Smith LeAnn B filed to sell 2,871 shares at $715.2. May 28 '25 |
Vitalone Britt J. filed to sell 14,760 shares at $717.3. May 23 '25 |
Similar companies
Company | Price | AI Score | |
---|---|---|---|
![]() |
Teladoc HealthTDOC |
$6.97 0% | 35 |
![]() |
Veeva SystemsVEEV |
$234.49 0% | 42 |
![]() |
DoximityDOCS |
$51.64 0% | 60 |
![]() |
GoodRxGDRX |
$3.79 0% | 49 |
![]() |
Lifestance HealthLFST |
$6.04 0% | 62 |
Congress Trading View All
Politician | Filing Date | Type | Size |
---|---|---|---|
Gil Cisneros |
May 7, 25 | Buy | $1K - $15K |
Jonathan Jackson |
Apr 8, 25 | Buy | $1K - $15K |
Gil Cisneros |
Feb 12, 25 | Sell | $1K - $15K |
Read more about McKesson (MCK) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of McKesson?
The Market Cap of McKesson is $90B.
What is McKesson's PE Ratio?
As of today, McKesson's PE (Price to Earnings) ratio is 27.86.
What is the current stock price of McKesson?
Currently, the price of one share of McKesson stock is $712.13.
How can I analyze the MCK stock price chart for investment decisions?
The MCK stock price chart above provides a comprehensive visual representation of McKesson's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling McKesson shares. Our platform offers an up-to-date MCK stock price chart, along with technical data analysis and alternative data insights.
Does MCK offer dividends to its shareholders?
Yes, McKesson (MCK) offers dividends to its shareholders, with a dividend yield of 0.4%. This dividend yield represents McKesson's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering McKesson in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of McKesson?
Some of the similar stocks of McKesson are Teladoc Health, Veeva Systems, Doximity, GoodRx, and Lifestance Health.
.